ISSN 1977-091X doi:10.3000/1977091X.C_2012.094.eng |
||
Official Journal of the European Union |
C 94 |
|
English edition |
Information and Notices |
Volume 55 |
Notice No |
Contents |
page |
|
IV Notices |
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2012/C 094/01 |
||
2012/C 094/02 |
||
EN |
|
IV Notices
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
30.3.2012 |
EN |
Official Journal of the European Union |
C 94/1 |
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2012 to 29 February 2012
(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1) )
2012/C 94/01
— Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted
Date of the decision |
Name of the medicinal product |
INN (International Non-Proprietary Name) |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Pharmaceutical form |
ATC code (Anatomical Therapeutic Chemical Code) |
Date of notification |
|||||
13.2.2012 |
Colobreathe |
Colistimethate sodium |
|
EU/1/11/747/001 |
Inhalation powder, hard capsule |
R07AX |
15.2.2012 |
|||||
17.2.2012 |
Caprelsa |
vandetanib |
|
EU/1/11/749/001-002 |
Film-coated tablet |
L01XE12 |
21.2.2012 |
|||||
17.2.2012 |
Vepacel |
Prepandemic influenza vaccine (A/H5N1) (whole virion, Vero cell derived, inactivated) |
|
EU/1/12/752/001 |
Suspension for injection |
J07BB01 |
21.2.2012 |
|||||
17.2.2012 |
Zelboraf |
vemurafenib |
|
EU/1/12/751/001 |
Film-coated tablet |
L01XE15 |
21.2.2012 |
|||||
23.2.2012 |
Esmya |
ulipristal |
|
EU/1/12/750/001 |
Tablet |
Pending |
28.2.2012 |
— Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Rejected
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||||
9.2.2012 |
Sumatriptan Galpharm |
|
|
13.2.2012 |
— Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||||||
6.2.2012 |
Aclasta |
|
EU/1/05/308/001-002 |
9.2.2012 |
|||||||
6.2.2012 |
Aflunov |
|
EU/1/10/658/001-002 |
9.2.2012 |
|||||||
6.2.2012 |
Ambirix |
|
EU/1/02/224/001-005 |
8.2.2012 |
|||||||
6.2.2012 |
Avastin |
|
EU/1/04/300/001-002 |
9.2.2012 |
|||||||
6.2.2012 |
Corlentor |
|
EU/1/05/317/001-014 |
8.2.2012 |
|||||||
6.2.2012 |
Dificlir |
|
EU/1/11/733/001-004 |
9.2.2012 |
|||||||
6.2.2012 |
Erbitux |
|
EU/1/04/281/001-005 |
8.2.2012 |
|||||||
6.2.2012 |
Intanza |
|
EU/1/08/505/001-006 |
8.12.2012 |
|||||||
6.2.2012 |
Olanzapine Apotex |
|
EU/1/10/635/001-018 |
8.2.2012 |
|||||||
6.2.2012 |
Optimark |
|
EU/1/07/398/001-014 |
8.2.2012 |
|||||||
6.2.2012 |
Orencia |
|
EU/1/07/389/001-003 |
8.2.2012 |
|||||||
6.2.2012 |
Prialt |
|
EU/1/04/302/001-004 |
8.2.2012 |
|||||||
6.2.2012 |
Rapamune |
|
EU/1/01/171/001 |
9.2.2012 |
|||||||
6.2.2012 |
Remicade |
|
EU/1/99/116/001-005 |
8.2.2012 |
|||||||
6.2.2012 |
Rilonacept Regeneron |
|
EU/1/09/582/001 |
9.2.2012 |
|||||||
6.2.2012 |
Simponi |
|
EU/1/09/546/001-004 |
8.2.2012 |
|||||||
6.2.2012 |
Sonata |
|
EU/1/99/102/001-006 |
8.2.2012 |
|||||||
6.2.2012 |
Taxotere |
|
EU/1/95/002/001-005 |
8.2.2012 |
|||||||
6.2.2012 |
Tevagrastim |
|
EU/1/08/445/001-014 |
8.2.2012 |
|||||||
6.2.2012 |
Votubia |
|
EU/1/11/710/001-007 |
9.2.2012 |
|||||||
6.2.2012 |
Yellox |
|
EU/1/11/692/001 |
9.2.2012 |
|||||||
9.2.2012 |
Aerius |
|
EU/1/00/160/001-013 EU/1/00/160/022-034 EU/1/00/160/036-069 |
13.2.2012 |
|||||||
9.2.2012 |
Arzerra |
|
EU/1/10/625/001 EU/1/10/625/003 |
13.2.2012 |
|||||||
9.2.2012 |
Azomyr |
|
EU/1/00/157/001-013 EU/1/00/157/022-067 |
13.2.2012 |
|||||||
9.2.2012 |
Olazax Disperzi |
|
EU/1/09/592/001-005 |
13.2.2012 |
|||||||
9.2.2012 |
Pradaxa |
|
EU/1/08/442/001-014 |
13.2.2012 |
|||||||
9.2.2012 |
Prepandemic Influenza |
|
EU/1/10/657/001-002 |
13.2.2012 |
|||||||
9.2.2012 |
Prepandemic Influenza |
|
EU/1/10/657/001-002 |
13.2.2012 |
|||||||
9.2.2012 |
Procoralan |
|
EU/1/05/316/001-014 |
13.2.2012 |
|||||||
9.2.2012 |
Rivastigmine HEXAL |
|
EU/1/09/589/001-018 |
13.2.2012 |
|||||||
13.2.2012 |
Circadin |
|
EU/1/07/392/001-003 |
15.2.2012 |
|||||||
13.2.2012 |
Cystadane |
|
EU/1/06/379/001 |
15.2.2012 |
|||||||
17.2.2012 |
Aerinaze |
|
EU/1/07/399/001-006 |
21.2.2012 |
|||||||
17.2.2012 |
Elonva |
|
EU/1/09/609/001-002 |
22.2.2012 |
|||||||
17.2.2012 |
Fablyn |
|
EU/1/08/500/001-004 |
22.2.2012 |
|||||||
17.2.2012 |
Faslodex |
|
EU/1/03/269/001-002 |
22.2.2012 |
|||||||
17.2.2012 |
Gliolan |
|
EU/1/07/413/001-003 |
22.2.2012 |
|||||||
17.2.2012 |
Herceptin |
|
EU/1/00/145/001 |
21.2.2012 |
|||||||
17.2.2012 |
Isentress |
|
EU/1/07/436/001-002 |
21.2.2012 |
|||||||
17.2.2012 |
Myocet |
|
EU/1/00/141/001-002 |
22.2.2012 |
|||||||
17.2.2012 |
Neoclarityn |
|
|
22.2.2012 |
|||||||
17.2.2012 |
Olanzapine Teva |
|
EU/1/07/427/001-057 |
21.2.2012 |
|||||||
17.2.2012 |
Olazax |
|
EU/1/09/597/001-005 |
21.2.2012 |
|||||||
17.2.2012 |
Replagal |
|
EU/1/01/189/001-006 |
22.2.2012 |
|||||||
17.2.2012 |
Rivastigmine 1 A Pharma |
|
EU/1/09/585/001-018 |
22.2.2012 |
|||||||
17.2.2012 |
Rivastigmine Sandoz |
|
EU/1/09/599/001-018 |
21.2.2012 |
|||||||
17.2.2012 |
Tractocile |
|
EU/1/99/124/001-002 |
21.2.2012 |
|||||||
17.2.2012 |
Vectibix |
|
EU/1/07/423/001-003 |
22.2.2012 |
|||||||
21.2.2012 |
Aloxi |
|
EU/1/04/306/001-003 |
23.2.2012 |
|||||||
21.2.2012 |
Angiox |
|
EU/1/04/289/001 |
23.2.2012 |
|||||||
21.2.2012 |
Cholestagel |
|
EU/1/03/268/001-004 |
24.2.2012 |
|||||||
21.2.2012 |
Cubicin |
|
EU/1/05/328/001-004 |
24.2.2012 |
|||||||
21.2.2012 |
Evra |
|
EU/1/02/223/001-003 |
24.2.2012 |
|||||||
21.2.2012 |
Fertavid |
|
EU/1/09/510/001-019 |
24.2.2012 |
|||||||
21.2.2012 |
Glivec |
|
EU/1/01/198/001-013 |
23.2.2012 |
|||||||
21.2.2012 |
Kaletra |
|
EU/1/01/172/001-008 |
23.2.2012 |
|||||||
21.2.2012 |
Levitra |
|
EU/1/03/248/001-023 |
23.2.2012 |
|||||||
21.2.2012 |
Mimpara |
|
EU/1/04/292/001-012 |
23.2.2012 |
|||||||
21.2.2012 |
PREZISTA |
|
EU/1/06/380/001-005 |
23.2.2012 |
|||||||
21.2.2012 |
ProQuad |
|
EU/1/05/323/001-013 |
24.2.2012 |
|||||||
21.2.2012 |
Remicade |
|
EU/1/99/116/001-005 |
23.2.2012 |
|||||||
21.2.2012 |
RotaTeq |
|
EU/1/06/348/001-002 |
24.2.2012 |
|||||||
21.2.2012 |
Sprycel |
|
EU/1/06/363/001-015 |
23.2.2012 |
|||||||
21.2.2012 |
Stelara |
|
EU/1/08/494/001-004 |
24.2.2012 |
|||||||
21.2.2012 |
Vfend |
|
EU/1/02/212/001-026 |
23.2.2012 |
|||||||
21.2.2012 |
Victoza |
|
EU/1/09/529/001-005 |
24.2.2012 |
|||||||
21.2.2012 |
Vimpat |
|
EU/1/08/470/001-019 |
23.2.2012 |
|||||||
21.2.2012 |
Visudyne |
|
EU/1/00/140/001 |
23.2.2012 |
|||||||
21.2.2012 |
Vivanza |
|
EU/1/03/249/001-015 |
24.2.2012 |
|||||||
21.2.2012 |
Zostavax |
|
EU/1/06/341/001-013 |
24.2.2012 |
|||||||
23.2.2012 |
Clopidogrel Qualimed |
|
EU/1/09/557/001-010 |
27.2.2012 |
|||||||
23.2.2012 |
Januvia |
|
EU/1/07/383/001-018 |
27.2.2012 |
|||||||
23.2.2012 |
Resolor |
|
EU/1/09/581/001-008 |
27.2.2012 |
|||||||
27.2.2012 |
Bridion |
|
EU/1/08/466/001-002 |
29.2.2012 |
|||||||
27.2.2012 |
Evicel |
|
EU/1/08/473/001-003 |
29.2.2012 |
|||||||
27.2.2012 |
Instanyl |
|
EU/1/09/531/001-021 |
29.2.2012 |
|||||||
27.2.2012 |
Irbesartan HCT Zentiva (Ex-Winthrop) |
|
EU/1/06/377/001-028 |
1.3.2012 |
|||||||
27.2.2012 |
Olanzapine Glenmark |
|
EU/1/09/587/001-017 |
29.2.2012 |
|||||||
27.2.2012 |
Olanzapine Glenmark Europe |
|
EU/1/09/588/001-012 |
29.2.2012 |
|||||||
27.2.2012 |
Prolia |
|
EU/1/10/618/001-004 |
29.2.2012 |
|||||||
27.2.2012 |
Twynsta |
|
EU/1/10/648/001-028 |
29.2.2012 |
— Withdrawal of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
||||
9.2.2012 |
Clopidogrel Acino Pharma |
|
EU/1/09/549/001-007 |
13.2.2012 |
||||
9.2.2012 |
Clopidogrel Hexal |
|
EU/1/09/534/001-007 |
13.2.2012 |
||||
13.2.2012 |
Clopidogrel Acino Pharma GmbH |
|
EU/1/09/548/001-007 |
15.2.2012 |
— Issuing of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (2) ): Accepted
Date of the Décision |
Name of the medicinal product |
INN (International Non-Proprietary Name) |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Pharmaceutical form |
ATC code (Anatomical Therapeutic Chemical Code) |
Date of notification |
|||||
23.2.2012 |
RevitaCAM |
Meloxicam |
|
EU/2/12/138/001-003 |
Oromucosal spray |
QM01AC06 |
27.2.2012 |
— Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||||
17.2.2012 |
Purevax Rabies |
|
EU/2/10/117/001-003 |
21.2.2012 |
|||||
21.2.2012 |
Dicural |
|
EU/2/97/003/001-018 |
24.2.2012 |
|||||
27.2.2012 |
Reconcile |
|
EU/2/08/080/001-004 |
29.2.2012 |
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
The European Medicines Agency |
7, Westferry Circus |
Canary Wharf |
UK - LONDON E14 4H |
(1) OJ L 136, 30.4.2004, p. 1.
(2) OJ L 136, 30.4.2004, p. 1.
30.3.2012 |
EN |
Official Journal of the European Union |
C 94/13 |
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2012 to 29 February 2012
(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2) )
2012/C 94/02
— Issuing, maintenance or modification of a national marketing authorization
Date of the decision |
Name(s) of the medicinal product |
Holder(s) of the marketing authorization |
Member State concerned |
Date of notification |
6.2.2012 |
Fortekor and associated names - |
See Annex I |
See Annex I |
8.2.2012 |
27.2.2012 |
Somatropin |
See Annex II |
See Annex II |
29.2.2012 |
17.2.2012 |
Pholcodine-containing medicinal products - Art 31 (maintain) |
See Annex III |
See Annex III |
20.2.2012 |
— Suspension of a national marketing authorization
Date of the decision |
Name(s) of the medicinal product |
Holder(s) of the marketing authorization |
Member State concerned |
Date of notification |
13.2.2012 |
Buflomedil |
See Annex IV |
See Annex IV |
14.2.2012 |
(1) OJ L 311, 28.11.2001, p. 67.
(2) OJ L 311, 28.11.2001, p. 1.
ANNEX I
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE VETERINARY MEDICINAL PRODUCTS, ANIMAL SPECIES, INDICATIONS, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Marketing authorisation holder |
Name |
INN |
Strengths |
Pharmaceutical forms |
Animal species |
Indications |
||||||
Austria |
|
Fortekor 5 mg - Filmtabletten für Hunde und Katzen |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Treatment of heart failure in dogs Treatment of chronic renal insufficiency in cats |
||||||
Austria |
|
Fortekor 20 mg - Filmtabletten für Hunde |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure in dogs |
||||||
Austria |
|
Fortekor 2,5 mg Gourmet |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Treatment of heart failure in dogs. Treatment of chronic renal insufficiency in cats |
||||||
Belgium |
|
FORTEKOR 5 |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Dog: Treatment of heart failure Cat: Retardation of chronic renal insufficiency by reducing the blood pressure. |
||||||
Belgium |
|
FORTEKOR FLAVOUR 5 |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Treatment of heart failure |
||||||
Belgium |
|
Fortekor 20 |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure |
||||||
Belgium |
|
Fortekor Flavour 20 |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Treatment of heart failure |
||||||
Belgium |
|
Fortekor 2,5 |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Dog: Treatment of heart failure Cat: Retardation of chronic renal insufficiency by reducing the blood pressure. |
||||||
Czech Republic |
|
FORTEKOR 5 mg potahované tablety |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Treatment of heart failure in dogs Treatment of chronic renal insufficiency in cats |
||||||
Czech Republic |
|
FORTEKOR 20 mg potahované tablety |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure in dogs |
||||||
Denmark |
|
Fortekor Vet. 5 mg |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Heart diseases in dogs |
||||||
Denmark |
|
Fortekor Vet. 20 mg |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Heart disease in dogs |
||||||
Denmark |
|
Fortekor Vet. 2,5 mg |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs |
Heart disease in dogs |
||||||
Finland |
|
Fortekor vet. 5 mg |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Heart failure in dogs |
||||||
Finland |
|
Fortekor vet. 20 mg |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Heart failure in dogs |
||||||
Finland |
|
Fortekor vet. 2,5 mg |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs |
Cardiac failure in dogs, chronic renal insufficiency in cats |
||||||
France |
|
FORTEKOR F 5 |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs and cats |
For dogs over 5 kg Treatment of heart failure For cats over 2,5 kg Treatment of chronic renal insufficiency |
||||||
France |
|
FORTEKOR F 20 |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
For dogs over 20 kg Treatment of heart failure |
||||||
France |
|
FORTEKOR 2,5 |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
For dogs over 2,5 kg Treatment of heart failure For cats over 2,5 kg Treatment of chronic renal insufficiency |
||||||
Germany |
|
Fortekor Flavour 2,5 mg |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs |
Treatment of heart failure in dogs, also in addition to the diuretic furosemide and/or the antiarrhythmic drug digoxin |
||||||
Germany |
|
Fortekor 5 |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure in dogs, also in addition to the diuretic furosemide and/or the antiarrhythmic drug digoxin |
||||||
Germany |
|
Fortekor Flavour 5 mg |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Treatment of heart failure in dogs, also in addition to the diuretic furosemide and/or the antiarrhythmic drug digoxin |
||||||
Germany |
|
Fortekor 20 |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure in dogs, also in addition to the diuretic furosemide and/or the antiarrhythmic drug digoxin |
||||||
Germany |
|
Fortekor Flavour 20 mg |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Treatment of heart failure in dogs, also in addition to the diuretic furosemide and/or the antiarrhythmic drug digoxin |
||||||
Greece |
|
FORTEKOR 5 mg |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure |
||||||
Greece |
|
FORTEKOR 20 mg |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure |
||||||
Greece |
|
FORTEKOR Flavour 5 |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Treatment of heart failure |
||||||
Greece |
|
FORTEKOR Flavour 20 |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Treatment of heart failure |
||||||
Hungary |
|
Fortekor 5 mg ízesített tabletta |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
For the treatment of heart failure in dogs. |
||||||
Hungary |
|
Fortekor 20 mg ízesített tabletta |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
For the treatment of heart failure in dogs. |
||||||
Ireland |
|
FORTEKOR 5 mg film-coated tablets for dogs and cats. |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Treatment of heart failure in dogs. Treatment of chronic renal insufficiency in cats. |
||||||
Ireland |
|
Fortekor 20 mg Film-coated tablets for Dogs |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Treatment of heart failure in dogs. |
||||||
Ireland |
|
Fortekor 2,5 mg tablets for Dogs and Cats |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Treatment of heart failure in dogs. Treatment of chronic renal insufficiency in cats. |
||||||
Italy |
|
Fortekor 5 |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Dogs: Treatment of heart failure at stages 2,3 and 4. For slowing the renal damage progression in chronic kidney disease with proteinuria. Cats: Treatment of chronic renal insufficiency. |
||||||
Italy |
|
Fortekor Flavour 5 |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Treatment of heart failure at 2nd- 3rd and 4th stage. Slow down of the progression of renal damage in chronic kidney disease with proteinuria. |
||||||
Italy |
|
Fortekor 20 |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Dogs: Treatment of heart failure at stages 2,3 and 4. For slowing the renal damage progression in chronic kidney disease with proteinuria. |
||||||
Italy |
|
Fortekor Flavour 20 |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Treatment of heart failure at 2nd- 3rd and 4th stage. Slow down of the progression of renal damage in chronic kidney disease with proteinuria. |
||||||
Italy |
|
Fortekor 2,5 |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Dogs: Treatment of heart failure at stages 2,3 and 4. For slowing the renal damage progression in chronic kidney disease with proteinuria. Cats: Treatment of chronic renal insufficiency. |
||||||
Luxembourg |
|
FORTEKOR 5 |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Dog: Treatment of heart failure Cat: Retardation of chronic renal insufficiency by reducing the blood pressure. |
||||||
Luxembourg |
|
FORTEKOR Flavour 5 |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Treatment of heart failure |
||||||
Luxembourg |
|
Fortekor 20 |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure |
||||||
Luxembourg |
|
Fortekor Flavour 20 |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Treatment of heart failure |
||||||
Luxembourg |
|
Fortekor 2,5 |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Dog: Treatment of heart failure Cat: Retardation of chronic renal insufficiency by reducing the blood pressure. |
||||||
Norway |
|
Fortekor vet 5 mg |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Treatment of heart failure, especially dilated cardiomyopathy and mitral failure. |
||||||
Norway |
|
Fortekor vet 20 mg |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Treatment of heart failure, especially dilated cardiomyopathy and mitral failure. |
||||||
Norway |
|
Fortekor vet 2,5 mg |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Dog: Treatment of heart failure, especially dilated cardiomyopathy and mitral failure. Cat: Experimentally to reduce proteinuria in chronic renal failure in which baseline protein/creatinine ratio PCR is > 1. |
||||||
Poland |
|
FORTEKOR 5, tabletki powlekane dla pśow i kotów |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
For dogs -Treatment of heart failure For cats -Treatment of chronic renal insufficiency |
||||||
Poland |
|
FORTEKOR 20, tabletki powlekane dla pśow |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
For dogs -Treatment of heart failure |
||||||
Portugal |
|
FORTEKOR 5 mg comprimidos revestidos para cães e gatos |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Dogs: Treatment of heart failure Cats: Treatment of renal insufficiency |
||||||
Portugal |
|
FORTEKOR Palatável 5 mg comprimidos para cães e gatos |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs and cats |
Dogs: Treatment of heart failure. Indicated in chronic renal insufficiency to slow its progression. Cats: Treatment of chronic renal insufficiency. |
||||||
Portugal |
|
FORTEKOR 20 mg comprimidos revestidos para cães |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Dogs: Treatment of heart failure |
||||||
Portugal |
|
FORTEKOR Palatável 20 mg comprimidos para cães |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Dogs: Treatment of heart failure. Indicated in chronic renal insufficiency to slow its progression. |
||||||
Portugal |
|
FORTEKOR Palatável 2,5 mg comprimidos para cães e gatos |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Dogs: Treatment of heart failure. Indicated in chronic renal insufficiency to slow its progression. Cats: Treatment of chronic renal insufficiency. |
||||||
Romania |
|
FORTEKOR 5 |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs |
For treatment of heart failure in dogs. |
||||||
Romania |
|
FORTEKOR 20 |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
For treatment of heart failure in dogs. |
||||||
Slovakia |
|
FORTEKOR 5 mg tbl.ad us.vet |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Treatment of heart failure in dogs. Treatment of chronic kidney insufficiency in cats. |
||||||
Slovenia |
|
FORTEKOR 5 mg filmsko obložene tablete za pse |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure in dogs. |
||||||
Slovenia |
|
FORTEKOR 20 mg filmsko obložene tablete za pse |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure in dogs. |
||||||
Spain |
|
FORTEKOR 5 |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Dogs: Treatment of heart failure. Diuretics and/or antiarrhythmics may be used with benazepril when judged appropriate by the veterinarian, but whenever it is thought to be appropriate benazepril alone may be used. Cats: Treatment of chronic renal insufficiency. |
||||||
Spain |
|
FORTEKOR SABOR 5 mg |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Dogs: Treatment of heart failure in dogs. It is indicated in chronic renal insufficiency to slow down its progression. |
||||||
Spain |
|
FORTEKOR 20 |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Dogs: Treatment of heart failure. Diuretics and/or antiarrhythmics may be used with benazepril when judged appropriate by the veterinarian, but whenever it is thought to be appropriate benazepril alone may be used. |
||||||
Spain |
|
FORTEKOR SABOR 20 mg |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Dogs: Treatment of heart failure in dogs. It is indicated in chronic renal insufficiency to slow down its progression. |
||||||
Spain |
|
FORTEKOR SABOR 2,5 mg |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Dogs: Treatment of heart failure in dogs. It is indicated in chronic renal insufficiency to slow down its progression. Cats: Treatment of chronic renal insufficiency. |
||||||
Sweden |
|
Fortekor vet 5 mg |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs |
Treatment of heart failure, especially dilated cardiomyopathy and mitral failure. |
||||||
Sweden |
|
Fortekor vet 20 mg |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Treatment of heart failure, especially dilated cardiomyopathy and mitral failure. |
||||||
Sweden |
|
Fortekor vet 2,5 mg |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs |
Treatment of heart failure, especially dilated cardiomyopathy and mitral failure. |
||||||
The Netherlands |
|
Fortekor 5 |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Dogs: For the symptomatic, adjunctive therapy in the treatment with the diuretic furosemide of heart failure caused by mitral failure or congestive cardiomyopathy. The treatment may improve the effort tolerance and increase survival of dogs with moderate to severe heart failure. Cats: Treatment of chronic renal failure. |
||||||
The Netherlands |
|
FORTEKOR FLAVOUR 5 |
Benazepril hydrochloride |
5 mg |
Tablets |
Dogs and cats |
Dogs: For the symptomatic, adjunctive therapy in the treatment with the diuretic furosemide of heart failure caused by mitral failure or congestive cardiomyopathy. The treatment may improve the effort tolerance and increase survival of dogs with moderate to severe heart failure. Cats: Treatment of chronic renal failure. |
||||||
The Netherlands |
|
Fortekor 20 |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Dogs: For the symptomatic, adjunctive therapy in the treatment with the diuretic furosemide of heart failure caused by mitral failure or congestive cardiomyopathy. The treatment may improve the effort tolerance and increase survival of dogs with moderate to severe heart failure. |
||||||
The Netherlands |
|
Fortekor Flavour 20 |
Benazepril hydrochloride |
20 mg |
Tablets |
Dogs |
Dogs: For the symptomatic, adjunctive therapy in the treatment with the diuretic furosemide of heart failure caused by mitral failure or congestive cardiomyopathy. |
||||||
The Netherlands |
|
Fortekor 2,5 |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Dogs: For the symptomatic, adjunctive therapy in the treatment with the diuretic furosemide of heart failure caused by mitral failure or congestive cardiomyopathy. Cats: Treatment of chronic renal failure. |
||||||
United Kingdom |
|
Fortekor 5 mg Film-coated Tablets for Dogs and Cats |
Benazepril hydrochloride |
5 mg |
Film-coated tablets |
Dogs and cats |
Treatment of heart failure in dogs. Treatment of chronic renal insufficiency in cats. |
||||||
United Kingdom |
|
Fortekor 20 mg Film-coated tablets for Dogs |
Benazepril hydrochloride |
20 mg |
Film-coated tablets |
Dogs |
Treatment of heart failure in dogs. |
||||||
United Kingdom |
|
Fortekor 2,5 mg tablets for Dogs and Cats |
Benazepril hydrochloride |
2,5 mg |
Tablets |
Dogs and cats |
Treatment of heart failure in dogs. Treatment of chronic renal insufficiency in cats. |
ANNEX II
LIST OF THE INVENTED NAME(S), PHARMACEUTICAL FORM(S), STRENGTH(S) OF THE MEDICINAL PRODUCT(S), ROUTE(S) OF ADMINISTRATION, MARKETING AUTHORISATION HOLDER(S) IN THE MEMBER STATES
Member State EU/EEA |
Marketing authorisaton holder |
Product name |
Strength |
Pharmaceutical form |
Route of administration |
|||||||
AT - Austria |
|
Genotropin 12 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
12 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Genotropin 5,3 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
5,3 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Genotropin MiniQuick 0,2 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
0,2 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Humatrope 12 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
12 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Humatrope 24 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
24 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Humatrope 6 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
6 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin FlexPro 10 mg/1,5 ml Injektionslösung in einem Fertigpen |
10 mg/1,5 ml |
solution for injection, in pre-filled pen |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin FlexPro 15 mg/1,5 ml Injektionslösung in einem Fertigpen |
15 mg/1,5 ml |
solution for injection, in pre-filled pen |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin FlexPro 5 mg/1,5 ml Injektionslösung in einem Fertigpen |
5 mg/1,5 ml |
solution for injection, in pre-filled pen |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin NordiFlex 10 mg/1,5 ml - Injektionslösung in einem Fertigpen |
10 mg/1,5 ml |
solution for injection, in pre-filled pen |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin NordiFlex 15 mg/1,5 ml - Injektionslösung in einem Fertigpen |
15 mg/1,5 ml |
solution for injection, in pre-filled pen |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin NordiFlex 5 mg/1,5 ml - Injektionslösung in einem Fertigpen |
5 mg/1,5 ml |
solution for injection, in pre-filled pen |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin SimpleXx 10 mg/1,5 ml - Injektionslösung |
10 mg/1,5 ml |
solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin SimpleXx 15 mg/1,5 ml - Injektionslösung |
15 mg/1,5 ml |
solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Norditropin SimpleXx 5 mg/1,5 ml - Injektionslösung |
5 mg/1,5 ml |
solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Saizen 8 mg click.easy - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
8 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Saizen 1,33 mg - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
1,33 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Saizen 5,83 mg/ml Injektionslösung |
5,83 mg/ml |
solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Saizen 8 mg/ml Injektionslösung |
8 mg/ml |
solution for injection |
Subcutaneous use |
|||||||
AT - Austria |
|
Zomacton 10 mg/ml Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze |
10 mg/ml |
powder and solvent for solution for injection in a prefilled pen |
Subcutaneous use |
|||||||
AT - Austria |
|
Zomacton 4 mg - Trockenstechampullen mit Lösungsmittel |
4 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm |
1,3 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm |
12 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm |
5 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm |
5,3 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
0,2 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
0,4 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
0,6 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
0,8 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
1 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
1,2 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
1,4 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
1,6 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
1,8 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Genotonorm Miniquick |
2 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Humatrope |
6 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Humatrope |
12 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Humatrope |
24 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Flexpro |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Flexpro |
15 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Flexpro |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Nordiflex |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Nordiflex |
15 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Nordiflex |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Simplexx |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Simplexx |
15 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Norditropin Simplexx |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Zomacton |
10 mg/ml |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BE - Belgium |
|
Zomacton |
4 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
BG - Bulgaria |
|
Zomacton |
4 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
BG - Bulgaria |
|
Genotropin |
16 IU (5,3 mg) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
BG - Bulgaria |
|
Genotropin |
36 IU (12 mg) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
BG - Bulgaria |
|
Norditropin Simplex |
5 mg/1,5 ml |
solution for injection |
subcutaneous use |
|||||||
CY - Cyprus |
|
NORDITROPIN SIMPLEXx SOLUTION FOR INJECTION 5 MG/1,5 ML |
5 mg/1,5 ml |
SOLUTION FOR INJECTION |
SUBCUTANEOUS INJECTION |
|||||||
CY - Cyprus |
|
NORDITROPIN SIMPLEXx SOLUTION FOR INJECTION 10 MG/1,5 ML |
10 MG/1,5 ML |
SOLUTION FOR INJECTION |
SUBCUTANEOUS INJECTION |
|||||||
CY - Cyprus |
|
NORDITROPIN SIMPLEXx SOLUTION FOR INJECTION 15 MG/1,5 ML |
15 MG/1,5 ML |
SOLUTION FOR INJECTION |
SUBCUTANEOUS INJECTION |
|||||||
CY - Cyprus |
|
NORDITROPIN FLEX PRO 5 mg/1,5 ml PF PEN SOLUTION FOR INJECTION |
5 mg/1,5 ml |
SOLUTION FOR INJECTION IN A PRE-FILLED PEN |
SUBCUTANEOUS INJECTION |
|||||||
CY - Cyprus |
|
NORDITROPIN FLEX PRO 10 mg/1,5 ml SOL FOR INJECTION PF PEN |
10 MG/1,5 ML |
SOLUTION FOR INJECTION IN A PRE-FILLED PEN |
SUBCUTANEOUS INJECTION |
|||||||
CY - Cyprus |
|
NORDITROPIN FLEX PRO 15 mg/1,5 ml SOL FOR INJECTION PF PEN |
15 MG/1,5 ML |
SOLUTION FOR INJECTION IN A PRE-FILLED PEN |
SUBCUTANEOUS INJECTION |
|||||||
CZ - Czech Republic |
|
Norditropin SimpleXx 15 mg/1,5 ml |
10 MG/ML |
Solution for injection |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Norditropin SimpleXx 10 mg/1,5 ml |
6,7 MG/ML |
Solution for injection |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Norditropin SimpleXx 5 mg/1,5 ml |
3,3 MG/ML |
Solution for injection |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Saizen 8 mg click.easy |
5,83 MG/ML |
Powder and solvent for solution for infusion |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
SAIZEN 5,83 MG/ML INJEKČNÍ ROZTOK |
5,83 MG/ML |
Solution for injection |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
SAIZEN 8 MG/ML INJEKČNÍ ROZTOK |
8 MG/ML |
Solution for injection |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
GENOTROPIN 16 m.j. (5,3 mg) |
16 UT/ML |
Powder and solvent for solution for infusion |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
GENOTROPIN 36 m.j. (12 mg) |
36 UT/ML |
Powder and solvent for solution for infusion |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
ZOMACTON 4 mg |
1,3 mg/ml or 3,3 mg/ml after diluting with water |
Powder and solvent for solution for infusion |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Humatrope 18 IU (6 mg) |
18 UT |
Powder and solvent for solution for infusion |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Humatrope 36 IU (12 mg) |
36 UT |
Powder and solvent for solution for infusion |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Humatrope 72 IU (24 mg) |
72 UT |
Powder and solvent for solution for infusion |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
ZOMACTON 10 mg |
10 MG/1 ML |
Powder and solvent for solution for infusion |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Norditropin FlexPro 5 mg/1,5 ml |
5 MG/1,5 ML |
Solution for injection |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Norditropin FlexPro 10 mg/1,5 ml |
10 MG/1,5 ML |
Solution for injection |
subcutaneous use |
|||||||
CZ - Czech Republic |
|
Norditropin FlexPro 15 mg/1,5 ml |
15 MG/1,5 ML |
Solution for injection |
subcutaneous use |
|||||||
DE - Germany |
|
hGH-Ferring 12 (4 mg) |
4,32 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
ZOMACTON 10 mg/ml Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze |
10,0 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Zomacton 4 mg |
4,32 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Humatrope für Pen 12 mg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
12,0 mg |
Powder and solvent for solution for injection |
Subcutanous use, intramuscular use |
|||||||
DE - Germany |
|
Humatrope für Pen 24 mg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
24,0 mg |
Powder and solvent for solution for injection |
Subcutanous use, intramuscular use |
|||||||
DE - Germany |
|
Humatrope für Pen 6 mg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
6,0 mg |
Powder and solvent for solution for injection |
Subcutanous use, intramuscular use |
|||||||
DE - Germany |
|
Saizen 8 mg click.easy |
8,0 mg |
Powder and solvent for solution for injection |
Subcutanous use, intramuscular use |
|||||||
DE - Germany |
|
Norditropin FlexPro 10 mg/1,5 ml Injektionslösung in einem Fertigpen |
6,7 mg |
Solution for injection, in pre-filled pen |
Subcutanous use |
|||||||
DE - Germany |
|
Norditropin FlexPro 15 mg/1,5 ml Injektionslösung in einem Fertigpen |
10,0 mg |
Solution for injection, in pre-filled pen |
Subcutanous use |
|||||||
DE - Germany |
|
Norditropin FlexPro 5 mg/1,5 ml Injektionslösung in einem Fertigpen |
3,3 mg |
Solution for injection, in pre-filled pen |
Subcutanous use |
|||||||
DE - Germany |
|
Norditropin NordiFlex 10 mg/1,5 ml Injektionslöung in einem Fertigpen |
6,7 mg |
Solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Norditropin NordiFlex 15 mg/1,5 ml Injektionslöung in einem Fertigpen |
10,0 mg |
Solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Norditropin NordiFlex 5 mg/1,5 ml Injektionslöung in einem Fertigpen |
3,3 mg |
Solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Norditropin Simplexx 10 mg/1,5 ml Injektionslösung |
10,0 mg |
Solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Norditropin Simplexx 15 mg/1,5 ml Injektionslösung |
15,0 mg |
Solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Norditropin Simplexx 5 mg/1,5 ml Injektionslösung |
5,0 mg |
Solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Genotropin 12 mg |
12,0 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Genotropin 5 mg/ml |
5,8 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
Genotropin 5,3 mg |
5,3 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 0,2 mg |
0,2 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 0,4 mg |
0,4 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 0,6 mg |
0,6 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 0,8 mg |
0,8 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 1,0 mg |
1,0 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 1,2 mg |
1,2 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 1,4 mg |
1,4 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 1,6 mg |
1,6 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 1,8 mg |
1,8 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DE - Germany |
|
GENOTROPIN MiniQuick 2,0 mg |
2,0 mg |
Powder and solvent for solution for injection |
Subcutanous use |
|||||||
DK - Denmark |
|
Genotropin |
1,3 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin |
5,3 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin |
5 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin |
12 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
0,2 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
0,4 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
0,6 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
0,8 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
1,0 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
1,2 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
1,4 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
1,6 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
1,8 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Genotropin Miniquick |
2,0 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Humatrope |
6 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Humatrope |
12 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Humatrope |
24 mg |
powder and solvens for injection, solution |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Flexpro |
10 mg/1,5 mL |
Solution for injection, prefilled pen |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Flexpro |
15 mg/1,5 mL |
Solution for injection, prefilled pen |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Flexpro |
5 mg/1,5 mL |
Solution for injection, prefilled pen |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin NordiFlex |
5 mg/1,5 mL |
Solution for injection, prefilled syringe |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin NordiFlex |
10 mg/1,5 mL |
Solution for injection, prefilled syringe |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin NordiFlex |
15 mg/1,5 mL |
Solution for injection, prefilled syringe |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Nordilet |
5 mg/1,5 mL |
Solution for injection, prefilled syringe |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Nordilet |
10 mg/1,5 mL |
Solution for injection, prefilled syringe |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Nordilet |
15 mg/1,5 mL |
Solution for injection, prefilled syringe |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Simplexx |
5 mg/1,5 mL |
Solution for injection |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Simplexx |
10 mg/1,5 mL |
Solution for injection |
subcutaneous use |
|||||||
DK - Denmark |
|
Norditropin Simplexx |
15 mg/1,5 mL |
Solution for injection |
subcutaneous use |
|||||||
DK - Denmark |
|
Zomacton |
4 mg |
powder and solvens for solution for injection |
subcutaneous use |
|||||||
DK - Denmark |
|
Zomacton |
10 mg/mL |
powder and solvens for solution for injection, prefilled syringe |
subcutaneous use |
|||||||
EL - Greece |
|
NORDITROPIN SIMPLEXX |
5 MG/1,5 ML CARTRIDGE |
Solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
NORDITROPIN SIMPLEXX |
10 MG/1,5 ML CARTRIDGE |
Solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
NORDITROPIN SIMPLEXX |
15 MG/1,5 ML CARTRIDGE |
Solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
NORDITROPIN FLEXPRO |
5 MG/1,5 ML |
Injection Solution Prefilled Syringe |
Subcutaneous |
|||||||
EL - Greece |
|
NORDITROPIN FLEXPRO |
10 MG/1,5 ML |
Injection Solution Prefilled Syringe |
Subcutaneous |
|||||||
EL - Greece |
|
NORDITROPIN FLEXPRO |
15 MG/1,5 ML |
Injection Solution Prefilled Syringe |
Subcutaneous |
|||||||
EL - Greece |
|
GENOTROPIN |
5 mg /CARTRIDGE |
Powder and Solvent for Solution for Injection in cartridge |
Subcutaneous use |
|||||||
EL - Greece |
|
GENOTROPIN(WITH PRESERVATIVE) |
5,3 mg /CARTRIDGE |
Powder and Solvent for Solution for Injection in cartridge |
Subcutaneous use |
|||||||
EL - Greece |
|
GENOTROPIN(WITH PRESERVATIVE) |
12 mg /CARTRIDGE |
Powder and Solvent for Solution for Injection in cartridge |
Subcutaneous use |
|||||||
EL - Greece |
|
GENOTROPIN |
1 mg /CARTRIDGE |
Powder and Solvent for Solution for Injection in cartridge |
Subcutaneous use |
|||||||
EL - Greece |
|
GENOTROPIN |
1,4 mg /CARTRIDGE |
Powder and Solvent for Solution for Injection in cartridge |
Subcutaneous use |
|||||||
EL - Greece |
|
GENOTROPIN |
2 mg (6IU) /CARTRIDGE |
Powder and Solvent for Solution for Injection in cartridge |
Subcutaneous use |
|||||||
EL - Greece |
|
GENOTROPIN |
5 mg /CARTRIDGE with preservative |
Powder and Solvent for Solution for Injection in cartridge |
Subcutaneous use |
|||||||
EL - Greece |
|
SAIZEN |
3,33 MG/VIAL (MULTI DO |
Powder and Solvent for solution for Injection |
Subcutaneous Intramuscular |
|||||||
EL - Greece |
|
SAIZEN |
8 MG/VIAL |
Powder and Solvent for solution for Injection |
Subcutaneous Intramuscular |
|||||||
EL - Greece |
|
SAIZEN |
5,83 MG/VIAL |
Solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
SAIZEN |
8 MG/ML |
Solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
HUMATROPE |
6 MG/ CARTRIDGE |
Powder and Solvent for solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
HUMATROPE |
12 MG/ CARTRIDGE |
Powder and Solvent for solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
HUMATROPE |
24 MG/ CARTRIDGE |
Powder and Solvent for solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
ZOMACTON |
4 MG/VIAL |
Powder and Solvent for solution for Injection |
Subcutaneous |
|||||||
EL - Greece |
|
ZOMACTON |
10 MG/VIAL + 1 ML SOLV |
Powder and Solvent for solution for Injection |
Subcutaneous |
|||||||
ES - Spain |
|
HUMATROPE 6 mg polvo y disolvente para solución inyectable |
6 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
HUMATROPE 12 mg polvo y disolvente para solución inyectable |
12 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
HUMATROPE 24 mg polvo y disolvente para solución inyectable |
24 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 0,2 mg polvo y disolvente para solución inyectable |
0,2 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 0,4 mg polvo y disolvente para solución inyectable |
0,4 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 0,6 mg polvo y disolvente para solución inyectable |
0,6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 0,8 mg polvo y disolvente para solución inyectable |
0,8 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 1 mg polvo y disolvente para solución inyectable |
1,0 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 1,2 mg polvo y disolvente para solución inyectable |
1,2 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 1,4 mg polvo y disolvente para solución inyectable |
1,4 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 1,6 mg polvo y disolvente para solución inyectable |
1,6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 1,8 mg polvo y disolvente para solución inyectable |
1,8 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM MINIQUICK 2 mg polvo y disolvente para solución inyectable |
2 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM KABIPEN 5,3 mg polvo y disolvente para solución inyectable |
5,3 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM KABIPEN 12 mg polvo y disolvente para solución inyectable |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
ES - Spain |
|
GENOTONORM KABIPEN 12 mg polvo y disolvente para solución inyectable |
12 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
NORDITROPIN NORDIFLEX 5 mg / 1,5 ml solución inyectable |
5 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
NORDITROPIN NORDIFLEX 10 mg/1,5 ml solución inyectable |
10 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
NORDITROPIN NORDIFLEX 15 mg/1,5 ml solución inyectable |
15 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
NORDITROPIN SIMPLEXx 5 mg/1,5 ml solución inyectable |
5 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
NORDITROPIN SIMPLEXx 10 mg/1,5 ml solución inyectable |
10 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
NORDITROPIN SIMPLEXx 15 mg/1,5 ml solución inyectable |
15 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
ZOMACTON 10 mg/ ml polvo y disolvente en jeringa precargada para solución inyectable |
10 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
SAIZEN 8 mg click.easy polvo y disolvente para solución inyectable |
8 mg |
powder for solution |
Subcutaneous use |
|||||||
ES - Spain |
|
ZOMACTON 4 mg polvo y disolvente en jeringa precargada para solución inyectable |
4 mg |
powder for solution |
Subcutaneous use |
|||||||
ET - Estonia |
|
ZOMACTON |
4 mg |
Powder and solvent for solution for injection in pre-filled syringe |
subcutaneous use |
|||||||
ET - Estonia |
|
ZOMACTON |
10 mg |
Powder and solvent for solution for injection in pre-filled syringe |
subcutaneous use |
|||||||
ET - Estonia |
|
SAIZEN 8 MG CLICK.EASY |
8 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
ET - Estonia |
|
GENOTROPIN |
5,3 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
ET - Estonia |
|
GENOTROPIN |
12 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FI - Finland |
|
Zomacton |
10 mg/ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Zomacton |
4 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Saizen click.easy |
8 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Saizen |
8 mg/ml |
Solution for Injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Saizen |
5,83 mg/ml |
Solution for Injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Humatrope |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Humatrope |
24 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Humatrope |
6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Genotropin |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Genotropin |
5 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Flexpro |
5 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Flexpro |
10 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Flexpro |
15 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Nordiflex |
5 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Nordiflex |
10 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Nordiflex |
15 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Simplexx |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Simplexx |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
FI - Finland |
|
Norditropin Simplexx |
15 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
FR - France |
|
GENOTONORM 12 mg, poudre et solvant pour solution injectable |
12 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM 5 mg, poudre et solvant pour solution injectable |
5 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM 5,3 mg, poudre et solvant pour solution injectable |
5,3 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 0,2 mg, poudre et solvant pour solution injectable |
0,2 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 0,4 mg, poudre et solvant pour solution injectable |
0,4 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 0,6 mg, poudre et solvant pour solution injectable |
0,6 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 0,8 mg, poudre et solvant pour solution injectable |
0,8 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 1 mg, poudre et solvant pour solution injectable |
1 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 1,2 mg, poudre et solvant pour solution injectable |
1,2 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 1,4 mg, poudre et solvant pour solution injectable |
1,4 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 1,6 mg, poudre et solvant pour solution injectable |
1,6 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 1,8 mg, poudre et solvant pour solution injectable |
1,8 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
GENOTONORM MINIQUICK 2 mg, poudre et solvant pour solution injectable |
2 mg |
Powder and solvent for solution for injection |
subcutaneous use |
|||||||
FR - France |
|
MAXOMAT 1,3 mg, poudre et solvant pour solution injectable |
1,3 mg |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE NORDIFLEX 10 mg/1,5 ml, solution injectable en stylo prérempli |
10 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE NORDIFLEX 15 mg/1,5 ml, solution injectable en stylo prérempli |
15 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE NORDIFLEX 5 mg/1,5 ml, solution injectable en stylo prérempli |
5 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE FLEXPRO 10 mg/1,5 ml, solution injectable en stylo prérempli |
10 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE FLEXPRO 15 mg/1,5 ml, solution injectable en stylo prérempli |
15 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE FLEXPRO 5 mg/1,5 ml, solution injectable en stylo prérempli |
5 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE SIMPLEXX 10 mg/1,5 ml, solution injectable |
10 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE SIMPLEXX 15 mg/1,5 ml, solution injectable |
15 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
NORDITROPINE SIMPLEXX 5 mg/1,5 ml, solution injectable |
5 mg/1,5 ml |
Solution for injection |
subcutaneous |
|||||||
FR - France |
|
UMATROPE 12 mg/3 ml, poudre et solvant pour solution injectable |
12 mg/3 ml |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
UMATROPE 24 mg/3 ml, poudre et solvant pour solution injectable |
24 mg/3 ml |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
UMATROPE 6 mg/3 ml, poudre et solvant pour solution injectable |
6 mg/3 ml |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
ZOMACTON 10 mg/ml, poudre et solvant pour solution injectable en seringue préremplie |
10 mg/ml |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
ZOMACTON 4 mg, poudre et solvant pour solution injectable en multidose |
4 mg |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
SAIZEN 1,33 mg, poudre et solvant pour solution injectable |
1,33 mg |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
SAIZEN 3,33 mg, poudre et solvant pour solution injectable |
3,33 |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
SAIZEN 8 mg, poudre et solvant pour solution injectable |
8 |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
FR - France |
|
SAIZEN CLICKEASY 8 mg, poudre et solvant pour solution injectable |
8 |
Powder and solvent for solution for injection |
subcutaneous |
|||||||
HU - Hungary |
|
HUMATROPE 18 NE (6 mg) injekció patronban |
1,9 mg/ml |
powder and solvent for injection |
subcutaneous use |
|||||||
HU - Hungary |
|
HUMATROPE 36 NE (12 mg) injekció patronban |
3,8 mg/ml |
powder and solvent for injection |
subcutaneous use |
|||||||
HU - Hungary |
|
HUMATROPE 72 NE (24 mg) injekció patronban |
7,6 mg/ml |
powder and solvent for injection |
subcutaneous use |
|||||||
HU - Hungary |
|
NORDITROPIN SimpleXx 5 mg/1,5 ml oldatos injekció |
3,3 mg/ml |
solution for injection |
subcutaneous use |
|||||||
HU - Hungary |
|
NORDITROPIN SimpleXx 10 mg/1,5 ml oldatos injekció |
6,7 mg/ml |
solution for injection |
subcutaneous use |
|||||||
HU - Hungary |
|
NORDITROPIN SimpleXx 15 mg/1,5 ml oldatos injekció |
10 mg/ml |
solution for injection |
subcutaneous use |
|||||||
HU - Hungary |
|
SAIZEN click easy 8 mg por és oldószer oldatos injekcióhoz |
8 mg (24 NE) /1,5 ml |
powder and solvent for solution for injection |
parenteral use |
|||||||
HU - Hungary |
|
ZOMACTON 4 mg por és oldószer oldatos injekcióhoz |
1,3 mg/ml or 3,3 mg/ml |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
HU - Hungary |
|
GENOTROPIN 5,3 mg por és oldószer oldatos injekcióhoz |
16 NE (5,3 mg/ml) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
HU - Hungary |
|
GENOTROPIN 12 mg por és oldószer oldatos injekcióhoz |
36 NE (12 mg/ml) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IE - Ireland |
|
Genotropin 5,3 mg powder and solvent for solution for injection |
5,3 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin 12 mg powder and solvent for solution for injection |
12 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick 0,2 mg, powder and solvent for solution for injection |
0,2 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick 0,4 mg, powder and solvent for solution for injection |
0,4 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick 0,6 mg, powder and solvent for solution for injection |
0,6 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick 0,8 mg, powder and solvent for solution for injection |
0,8 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick, 1,0 mg, powder and solvent for solution for injection |
1,0 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick, 1,2 mg, powder and solvent for solution for injection |
1,2 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genetropin MiniQuick, 1,4 mg powder and solvent for Solution for Injection |
1,4 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick, 1,6 mg, powder and solvent for solution for injection |
1,6 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick, 1,8 mg, powder and solvent for solution for injection |
1,8 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Genotropin MiniQuick, 2,0 mg, powder and solvent for solution for injection |
2,0 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Norditropin SimpleXx 5 mg / 1,5 ml, solution for injection. |
5 mg/1,5 ml |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Norditropin SimpleXx 10 mg / 1,5 ml, solution for injection |
10 mg/1,5 ml |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Norditropin SimpleXx 15 mg / 1,5 ml, solution for injection. |
15 mg/1,5 ml |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Norditropin NordiFlex 5 mg/1,5 ml, solution for injection, in pre-filled pen |
5 mg/1,5 ml |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Norditropin NordiFlex 10 mg/1,5 ml, solution for injection, in pre-filled pen |
10 mg/1,5 ml |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Norditropin NordiFlex 15 mg/1,5 ml, solution for injection, in pre-filled pen |
15 mg/1,5 ml |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Saizen 1,33 mg powder and solvent for solution for injection |
1,33 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Saizen 3,33 mg powder and solvent for solution for injection |
3,33 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Saizen 8 mg click.easy powder and solvent for solution for injection. |
8 mg |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Saizen 5,83 mg/ml Solution for Injection |
5,83 mg |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Saizen 8 mg/ml Solution for Injection |
8 mg |
solution for injection |
Subcutanous injection |
|||||||
IE - Ireland |
|
Zomacton 4 mg, powder and solvent for solution for injection |
4 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IE - Ireland |
|
Zomacton 10 mg, powder and solvent for solution for injection |
10 mg |
Powder and solvent for solution |
Subcutanous injection |
|||||||
IS - Iceland |
|
Genotropin |
5 mg |
Powder and solvent for solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Genotropin |
12 mg |
Powder and solvent for solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Genotropin |
5,3 mg |
Powder and solvent for solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Humatrop 24 mg |
24 mg /Cartridge |
Powder and solvent for solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Humatrop 6 mg |
6 mg /Cartridge |
Powder and solvent for solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Norditropin FlexPro |
15/1,5 mg/ml Pre-filled pen |
Solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Norditropin FlexPro |
10/1,5 mg/ml Pre-filled pen |
Solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Norditropin FlexPro |
5/1,5 mg/ml Pre-filled pen |
Solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Norditropin NordiFlex |
15/1,5 mg/ml /Cartridge |
Solution for injection, prefilled pen |
s.c. |
|||||||
IS - Iceland |
|
Norditropin NordiFlex |
10/1,5 mg/ml /Cartridge |
Solution for injection, prefilled pen |
s.c. |
|||||||
IS - Iceland |
|
Norditropin NordiFlex |
5/1,5 mg/ml /Cartridge |
Solution for injection, prefilled pen |
s.c. |
|||||||
IS - Iceland |
|
Norditropin SimplexX |
15/1,5 mg/ml/ Cartridge |
Solution for injection, Cartridge |
s.c. |
|||||||
IS - Iceland |
|
Norditropin SimplexX |
10/1,5 mg/ml/ Cartridge |
Solution for injection, Cartridge |
s.c. |
|||||||
IS - Iceland |
|
Norditropin SimplexX |
5/1,5 mg/ml/ Cartridge |
Solution for injection, Cartridge |
s.c. |
|||||||
IS - Iceland |
|
Saizen click easy 8 mg |
8 mg |
Powder and solvent for solution for injection |
s.c. |
|||||||
IS - Iceland |
|
Saizen 5,83 mg/ml 5,83 mg/ml |
5,83 mg/ml 5,8 mg/ml |
Solution for injection Single dose container |
s.c. |
|||||||
IS - Iceland |
|
Saizen 8 mg/ml 8 mg/ml |
Saizen 8 mg/ml 8 mg/ml |
Solution for injection Single dose container |
s.c. |
|||||||
IT - Italy |
|
Genotropin |
5,3 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin |
12 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
0,2 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
0,4 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
0,6 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
0,8 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
1 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
1,2 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
1,4 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
1,6 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
1,8 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
Genotropin Miniquick |
2 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
SAIZEN |
1,33 mg/ml |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
SAIZEN |
3,33 mg (0,67 mg/ml) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
SAIZEN |
8 mg (2,96 mg/ml) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
SAIZEN (CLICK.EASY) |
8 mg (5,83 mgml) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
SAIZEN |
5,83 mg/ml |
solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
SAIZEN |
8 mg/ml |
solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
ZOMACTION |
4 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
ZOMACTION |
10 mg/ml |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
HUMATROPE |
6 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
HUMATROPE |
12 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
HUMATROPE |
24 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
NORDITROPIN NORDIFLEX |
5 mg/1,5 ml |
solution for injection in pre-filled syringe |
subcutaneous use |
|||||||
IT - Italy |
|
NORDITROPIN NORDIFLEX |
10 mg/1,5 ml |
solution for injection in pre-filled syringe |
subcutaneous use |
|||||||
IT - Italy |
|
NORDITROPIN NORDIFLEX |
15 mg/1,5 ml |
solution for injection in pre-filled syringe |
subcutaneous use |
|||||||
IT - Italy |
|
NORDITROPIN SIMPLEXX |
5 mg/1,5 ml |
solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
NORDITROPIN SIMPLEXX |
10 mg/1,5 ml |
solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
NORDITROPIN SIMPLEXX |
15 mg/1,5 ml |
solution for injection |
subcutaneous use |
|||||||
IT - Italy |
|
ZIMOSER |
1,33 mg/ml |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
LT - Lithuania |
|
ZOMACTON |
10 mg/ml |
Powder and solvent for solution for injection in pre-filled syringe |
Subcutaneous use |
|||||||
LT - Lithuania |
|
ZOMACTON |
4 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LT - Lithuania |
|
Humatrope |
6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LT - Lithuania |
|
Humatrope |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LT - Lithuania |
|
Norditropin SimpleXx |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
LT - Lithuania |
|
Norditropin SimpleXx |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
LT - Lithuania |
|
Genotropin |
5,3 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LT - Lithuania |
|
Genotropin |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotorm |
1,3 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotorm |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotorm |
5 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotorm |
5,3 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
0,2 mg |
powder for solution for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
0,4 mg |
powder for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
0,6 mg |
powder for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
0,8 mg |
powder for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
1 mg |
powder for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
1,4 mg |
powder for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
1,5 mg |
powder for solution for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
1,6 mg |
powder for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
1,8 mg |
powder for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Genotonorm Miniquick |
2 mg |
powder for injection |
Subcutaneous use |
|||||||
LU - Luxembourg |
|
Zomacton |
12 UI |
powder for solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Norditropin Simplexx |
5 mg |
solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Norditropin Simplexx |
15 mg |
solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Norditropin Simplexx |
10 mg |
solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Norditropin Simplexx |
10 mg/1,5 ml |
solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Norditropin Nordiflex |
5 mg/1,5 ml |
solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Norditropin Nordiflex |
10 mg/1,5 ml |
solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Norditropin Nordiflex |
15 mg/1,5 ml |
solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Zomacton-10 |
10 mg |
powder & solvant for solution for injection |
subcutaneous |
|||||||
LU - Luxembourg |
|
Humatrope |
6 mg |
powder for injection |
subcutaneous & intramuscular |
|||||||
LU - Luxembourg |
|
Humatrope |
12 mg |
powder for injection |
subcutaneous & intramuscular |
|||||||
LU - Luxembourg |
|
Humatrope |
24 mg |
powder for injection |
subcutaneous & intramuscular |
|||||||
LV - Latvia |
|
Saizen 8 mg click.easy powder and solvent for solution for injection |
8 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LV - Latvia |
|
Zomacton 4 mg powder and solvent for solution for injection |
4 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LV - Latvia |
|
Zomacton 10 mg powder and solvent for solution for injection in pre-filled syringe |
4 mg |
powder and solvent for solution for injection in pre-filled syringe |
Subcutaneous use |
|||||||
LV - Latvia |
|
Genotropin 5,3 mg powder and solvent for solution for injection |
5,3 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
LV - Latvia |
|
Genotropin 12 mg powder and solvent for solution for injection |
12 mg |
powder and solvent for solution for injection |
Subcutaneous use |
|||||||
MT - Malta |
|
Saizen 8 mg click.easy |
8 MG |
Powder and solvent for solution for injection |
Subcutaneous Intramuscular |
|||||||
MT - Malta |
|
Humatrope |
6 MG |
Powder and Solvent for Solution for Injection |
Subcutaneous Intramuscular |
|||||||
MT - Malta |
|
Humatrope |
12 MG |
Powder and Solvent for Solution for Injection |
Subcutaneous Intramuscular |
|||||||
MT - Malta |
|
Humatrope |
24 MG |
Powder and Solvent for Solution for Injection |
Subcutaneous Intramuscular |
|||||||
MT - Malta |
|
Norditropin SimpleXx |
Somatropin 5 mg/1,5 ml Somatropin 10 mg/1,5 ml |
Solution for Injeciton |
Subcutaneous |
|||||||
MT - Malta |
|
Genotropin 5,3 mg powder and solvent for solution for injection |
5,3 mg/ml |
Powder and Solvent for Solution for Injection in cartridge |
Subcutaneous Use |
|||||||
NL - Netherlands |
|
Genotropin |
5 mg |
Powder and solvent for solution for injection (poeder en oplosmiddel voor oplossing voor injectie |
Subcutaneous use |
|||||||
NL - Netherlands |
|
Genotropin |
12 mg |
Powder and solvent for solution for injection (poeder en oplosmiddel voor oplossing voor injectie |
Subcutaneous use |
|||||||
NL - Netherlands |
|
Humatrope |
6, 12, 24 mg |
Powder and solvent for solution for injection (poeder en oplosmiddel voor oplossing voor injectie |
SC |
|||||||
NL - Netherlands |
|
Norditropin FlexPro |
5 mg/1,5 ml |
Solution for injection in pre-filled syringe (oplossing voor injectie in een voorgevulde) pen |
SC |
|||||||
NL - Netherlands |
|
Norditropin FlexPro |
10 mg/1,5 ml |
Solution for injection in pre-filled syringe (oplossing voor injectie in een voorgevulde) pen |
SC |
|||||||
NL - Netherlands |
|
Norditropin FlexPro |
15 mg/1,5 ml |
Solution for injection in pre-filled syringe (oplossing voor injectie in een voorgevulde) pen |
SC |
|||||||
NL - Netherlands |
|
Norditropin SimpleXx |
5 mg/1,5 ml |
Solution for injection (oplossing voor injectie) |
SC |
|||||||
NL - Netherlands |
|
Norditropin SimpleXx |
10 mg/1,5 ml |
Solution for injection (oplossing voor injectie) |
SC |
|||||||
NL - Netherlands |
|
Norditropin SimpleXx |
15 mg/1,5 ml |
Solution for injection (oplossing voor injectie) |
SC |
|||||||
NL - Netherlands |
|
Zomacton |
10 mg/ml |
Solution for injection in pre-filled-syringe (oplossing voor injectie in een voorgevulde spuit) |
SC |
|||||||
NL - Netherlands |
|
Zomacton |
4 mg/ml |
Powder for solution for injection (poeder voor injectievloeistof) |
sc |
|||||||
NO - Norway |
|
Genotropin |
0,2 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
0,4 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
0,6 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
0,8 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
1 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
1,2 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
1,4 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
1,6 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
1,8 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
2 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
5 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Genotropin |
12 mg |
powder and solution for injection |
Subcutaneous use |
|||||||
NO - Norway |
|
Humatrope |
6 mg |
powder and solution for injection |
injection |
|||||||
NO - Norway |
|
Humatrope |
12 mg |
powder and solution for injection |
injection |
|||||||
NO - Norway |
|
Humatrope |
24 mg |
powder and solution for injection |
injection |
|||||||
NO - Norway |
|
Norditropin SimpleXx |
5 mg / 1,5 mL |
solution for injection |
injection |
|||||||
NO - Norway |
|
Norditropin SimpleXx |
10 mg / 1,5 mL |
solution for injection |
injection |
|||||||
NO - Norway |
|
Norditropin SimpleXx |
15 mg/ 1,5 mL |
solution for injection |
injection |
|||||||
NO - Norway |
|
Saizen click easy |
8 mg |
powder and solution for injection |
injection |
|||||||
NO - Norway |
|
Zomacton |
4 mg |
powder and solution for injection |
injection |
|||||||
NO - Norway |
|
Norditropin NordiFlex |
5 mg/ 1,5 mL, |
solution for injection in prefilled syringe |
injection |
|||||||
NO - Norway |
|
Norditropin NordiFlex |
10 mg/ 1,5 mL |
solution for injection in prefilled syringe |
injection |
|||||||
NO - Norway |
|
Norditropin NordiFlex |
15 mg/ 1,5 mL |
solution for injection in prefilled syringe |
injection |
|||||||
PL - Poland |
|
Genotropin 5,3 |
16 j.m. (5,3 mg) |
Powder and solvent for solution for injection |
Subcutaneous Use |
|||||||
PL - Poland |
|
Genotropin 12 |
36 j.m. (12 mg) |
Powder and solvent for solution for injection |
Subcutaneous Use |
|||||||
PL - Poland |
|
Norditropin FlexPro |
5 g/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous |
|||||||
PL - Poland |
|
Norditropin SimpleXx |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous |
|||||||
PL - Poland |
|
Norditropin SimpleXx |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous |
|||||||
PL - Poland |
|
Saizen 8 mg click.easy |
24 j.m. (8 mg), [17,5 j.m. (5,83 mg)/ml] |
Powder and solvent for solution for injection |
Subcutaneous |
|||||||
PT - Portugal |
|
Zomacton |
4 mg/3,5 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Zomacton |
10 mg/ml |
Powder and solvent for solution for injection in pre-filled syringe |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin |
12 mg/1 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin |
5,3 mg/1 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
1 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
2 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
0,2 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
0,4 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
0,6 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
0,8 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
1,2 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
1,4 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
1,6 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin Miniquick |
1,8 mg/0,25 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Genotropin |
5 mg/1 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Humatrope |
6 mg/3,17 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Humatrope |
12 mg/3,15 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Humatrope |
24 mg/3,15 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Saizen |
1,3 mg/1 ml |
Powder and solvent for solution for injection |
Subcutaneous use; Intramuscular use |
|||||||
PT - Portugal |
|
Saizen |
3,3 mg/5 ml |
Powder and solvent for solution for injection |
Subcutaneous use; Intramuscular use |
|||||||
PT - Portugal |
|
Saizen |
8 mg/5 ml |
Powder and solvent for solution for injection |
Subcutaneous use; Intramuscular use |
|||||||
PT - Portugal |
|
Saizen "Click Easy" |
8 mg/1,37 ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Norditropin Nordiflex |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
PT – Portugal |
|
Norditropin Nordiflex |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Norditropin Nordiflex |
15 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Norditropin SimpleXx |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Norditropin SimpleXx |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Norditropin SimpleXx |
15 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
PT - Portugal |
|
Norditropin FlexPro |
5 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
PT - Portugal |
|
Norditropin FlexPro |
10 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
PT - Portugal |
|
Norditropin FlexPro |
15 mg/1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
RO - Romania |
|
GENOTROPIN 16 UI (5,3 mg) |
16 UI (5,3 mg) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
RO - Romania |
|
ZOMACTON 4 mg (12 UI) |
4 mg (12 UI) |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
RO - Romania |
|
Norditropin SimpleXx 5 mg/1,5 ml |
5 mg/1,5 ml |
solution for injection in cartridges |
subcutaneous use |
|||||||
RO - Romania |
|
NORDITROPIN FlexPro 5 mg/1,5 ml |
5 mg/1,5 ml |
solution for injection in pen |
subcutaneous use |
|||||||
RO - Romania |
|
NORDITROPIN FlexPro 10 mg/1,5 ml |
10 mg/1,5 ml |
solution for injection in pen |
subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin® |
5 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin® |
5,3 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin® |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
0,2 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
0,4 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
0,6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
0,8 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
1 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
1,2 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
1,4 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
1,6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
1,8 |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Genotropin Mini Quick |
2 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Norditropin NordiFlex® |
5 mg/1,5 ml |
Solution for injection, pre-filled pen |
Subcutaneous use |
|||||||
SE - Sweden |
|
Norditropin NordiFlex® |
10 mg/1,5 ml |
Solution for injection, pre-filled pen |
Subcutaneous use |
|||||||
SE - Sweden |
|
Norditropin NordiFlex® |
15 mg/1,5 ml |
Solution for injection, pre-filled pen |
Subcutaneous use |
|||||||
SE - Sweden |
|
Norditropin® SimpleXx® |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Norditropin® SimpleXx® |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Norditropin® SimpleXx® |
15 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Somatropin Novo Nordisk |
5 mg/1,5 ml |
Solution for injection, pre-filled pen |
Subcutaneous use |
|||||||
SE - Sweden |
|
Somatropin Novo Nordisk |
10 mg/1,5 ml |
Solution for injection, pre-filled pen |
Subcutaneous use |
|||||||
SE - Sweden |
|
Somatropin Novo Nordisk |
15 mg/1,5 ml |
Solution for injection, pre-filled pen |
Subcutaneous use |
|||||||
SE - Sweden |
|
Zomacton |
4 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Zomacton |
10 mg/ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Humatrope® |
6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Humatrope® |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Humatrope® |
24 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SE - Sweden |
|
Saizen® click.easy® |
8 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Genotropin 5,3 mg/ml prašek in vehikel za raztopino za injiciranje |
5,3 mg/ ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Genotropin 12 mg/ml prašek in vehikel za raztopino za injiciranje |
12 mg/ ml |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Humatrope 6 mg prašek in vehikel za raztopino in injiciranje |
6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Humatrope 12 mg prašek in vehikel za raztopino in injiciranje |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Humatrope 24 mg prašek in vehikel za raztopino in injiciranje |
24 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Norditropin FlexPro 10 mg/1,5 ml raztopina za injiciranje v napolnjenem injekcijskem peresniku |
6,7 mg/1 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Norditropin FlexPro 15 mg/1,5 ml raztopina za injiciranje v napolnjenem injekcijskem peresniku |
10 mg/1 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Norditropin SimpleXx 5 mg/ 1,5 ml raztopina za injiciranje v injekcijskem vložku |
3,3 mg/ 1 ml |
Solution for injection in cartridge |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Norditropin SimpleXx 10 mg/ 1,5 ml raztopina za injiciranje v injekcijskem vložku |
6,7 mg/ 1 ml |
Solution for injection in cartridge |
Subcutaneous use |
|||||||
SI - Slovenia |
|
Norditropin SimpleXx 15 mg/ 1,5 ml raztopina za injiciranje v injekcijskem vložku |
10 mg/ 1 ml |
Solution for injection in cartridge |
Subcutaneous use |
|||||||
SK - Slovakia |
|
GENOTROPIN 5,3 mg |
5,3 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
GENOTROPIN 12 mg |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
HUMATROPE 18 IU (6 mg) |
6 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
HUMATROPE 36 IU (12 mg) |
12 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
HUMATROPE 72 IU (24 mg) |
24 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Norditropin FlexPro 10 mg/1,5 ml |
10 mg/ 1,5 ml |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Norditropin FlexPro 5 mg/1,5 ml |
5 mg/ 1,5 mg |
Solution for injection in pre-filled pen |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Norditropin SimpleXx 10 mg/1,5 ml |
10 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Norditropin SimpleXx 5 mg/1,5 ml |
5 mg/1,5 ml |
Solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Saizen 5,83 mg/ ml injekčný roztok |
5,83 mg/1 ml |
Solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Saizen 8 mg/ ml injekčný roztok |
8 mg/1 ml |
Solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Saizen 8 mg click.easy |
8 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Zomacton 4 mg |
4 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
SK - Slovakia |
|
Zomacton 10 mg |
10 mg |
Powder and solvent for solution for injection |
Subcutaneous use |
|||||||
UK - United Kingdom |
|
Humatrope 6 mg For Injection |
6 mg |
powder for injection |
intramuscular and subcutaneous use |
|||||||
UK - United Kingdom |
|
Humatrope 12 mg For Injection |
12 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Humatrope 24 mg For Injection |
24 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin 5,3 mg |
5,3 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin 12 mg |
12 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 0,2 mg |
0,2 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 0,4 mg |
0,4 mg |
powder and solvent for solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 0,6 mg |
0,6 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 0,8 mg |
0,8 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 1 mg |
1 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 1,2 mg |
1,2 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 1,4 mg |
1,4 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 1,6 mg |
1,6 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 1,8 mg |
1,8 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Genotropin Miniquick 2 mg |
2 mg |
powder for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Simplexx 5 mg/1,5 ml |
5 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Simplexx 10 mg/1,5 ml |
10 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Simplexx 15 mg/1,5 ml |
15 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Flexpro 5 mg/1,5 ml |
5 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Flexpro 10 mg/1,5 ml |
10 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Flexpro 15 mg/1,5 ml |
15 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Nordiflex 5 mg/1,5 ml |
5 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Nordiflex 10 mg/1,5 ml |
10 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Norditropin Nordiflex 15 mg/1,5 ml |
15 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Zomacton 4 mg injection |
4 mg |
powder for solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Zomacton 10 mg powder for solution for injection (pre-filled syringe) |
10 mg |
powder for solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Saizen 4IU |
1,33 mg |
powder for injection |
intramuscular and subcutaneous use |
|||||||
UK - United Kingdom |
|
Saizen 10IU |
3,33 mg |
powder for injection |
intramuscular and subcutaneous use |
|||||||
UK - United Kingdom |
|
Saizen 8 mg ClickEasy |
8 mg |
powder for solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Saizen 5,83 mg/ml Solution for Injection |
5,83 mg |
solution for injection |
subcutaneous use |
|||||||
UK - United Kingdom |
|
Saizen 8 mg/ml Solution for Injection |
8 mg |
solution for injection |
subcutaneous use |
ANNEX III
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Marketing authorisation holder |
INN |
Strength |
Product name |
Pharmaceutical form |
Route of administration |
||||||
Belgium |
|
pholcodine 15 mg/15 ml Sulfogaiacol 300 mg/15 ml |
1,00 mg/ml (pholcodine) |
Broncho-Pectoralis Pholcodine |
Syrup |
Oral use |
||||||
Belgium |
|
pholcodine eucalyptolum camphora syntheticum gaiacolum phenolum |
10,00 mg 120 mg 156 mg 50 mg 10 mg |
Eucalyptine Pholcodine (Adult) |
Suppository |
Rectal use |
||||||
Belgium |
|
pholcodine eucalyptolum camphora syntheticum gaiacolum phenolum |
5,00 mg 80 mg 100 mg 30 mg 6 mg |
Eucalyptine Pholcodine (Child) |
Suppository |
Rectal use |
||||||
Belgium |
|
pholcodine 5 mg/5 ml Doxylaminii succinas 5 mg/5 ml Kalii guaiacolsulfonas 47,5 mg/5 ml Natrii benzoas 50 mg/5 ml |
1,00 mg/ml (pholcodine) |
Pholco-mereprine |
Syrup |
Oral use |
||||||
Belgium |
|
pholcodine 0,12 g |
1,20 mg/ml |
Cotrane Folcodine |
Syrup |
Oral use |
||||||
France |
|
myrte (huile essentielle de) (deterpenee); alpha-terpinéol; pholcodine |
0,05 g/100 g; 0,0025 g/100 g; 0,05 g/100 g |
Myrtine Enfants, sirop |
Syrup |
Oral use |
||||||
France |
|
coquelicot (petale de) (extrait sec de); pholcodine; sodium (benzoate de) |
0,2/100 g, 0,075 g/100 g 1 g/100 g |
Pulmadol Enfants, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,075 g/100 g |
Broncorinol toux seche enfants, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,100 g/100 g |
Broncorinol adultes toux seche pholcodine, sirop |
Syrup |
Oral use |
||||||
France |
|
biclotymol; chlorphénamine (maléate de); pholcodine |
0,2 g/100 ml; 0,012 g/100 ml; 0,120 g/100 ml |
Hexapneumine adultes, sirop |
Syrup |
Oral use |
||||||
France |
|
biclotymol; chlorphénamine (maléate de); pholcodine |
0,15/100 ml; 0,01 g/100 ml 0,1 g/100 ml |
Hexapneumine enfants, sirop |
Syrup |
Oral use |
||||||
France |
|
biclotymol; cinéole; pholcodine |
0,0800 g; 0,0700 g; 0,0050 g |
Hexapneumine enfants, suppositoire |
Suppository |
Rectal use |
||||||
France |
|
biclotymol; cinéole; pholcodine |
0,160 g; 0,140 g; 0,015 g |
Hexapneumine adultes, suppositoire |
Suppository |
Rectal use |
||||||
France |
|
pholcodine; sodium (benzoate de) |
0,0846 g/100 g; 2 g/100 g |
Pulmosodyl adulte, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine; érysimum (extrait sec d') |
1 mg/ml; 1,5 mg/ml |
Clarix toux seche pholcodine erysimum adultes, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine; érysimum (extrait sec d') |
0,1 g/100 ml; 0,150 g/100 ml |
Clarix toux seche pholcodine erysimum adultes sans sucre, sirop édulcoré au maltitol liquide et au cyclamate de sodium |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
133 mg/100 ml |
Dimetane sans sucre 133 mg/100 ml, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,0850 g/100 ml |
Codotussyl toux seche enfants, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
133 mg/100 ml |
Codotussyl toux seche adultes, sirop |
Syrup |
Oral use |
||||||
France |
|
cinéole; pholcodine |
0,05 g 0,005 g |
Codotussyl Enfants, suppositoire |
Suppository |
Rectal use |
||||||
France |
|
cinéole; pholcodine |
0,1 g; 0,02 g |
Codotussyl adultes, suppositoire |
Suppository |
Rectal use |
||||||
France |
|
chlorphénamine (maléate de); pholcodine |
0,01300 g/100 ml; 0,08 g/100 ml |
Broncalene adultes, sirop |
Syrup |
Oral use |
||||||
France |
|
chlorphénamine (maléate de); pholcodine |
0,01 g/100 ml; 0,0500 g/100 ml |
Broncalene enfants, sirop |
Syrup |
Oral use |
||||||
France |
|
chlorphénamine (maléate de); pholcodine |
0,0133 g/100 ml 0,08 g/100 ml |
Broncalene adultes sans sucre, sirop édulcoré à la saccharine sodique |
Syrup |
Oral use |
||||||
France |
|
guaïfénésine; pholcodine |
0,200 g/100 ml; 0,100 g/100 ml |
Ephedromel, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine; sulfogaïacol |
0,050 g/100 g; 3 g/100 g |
Pectoral Richelet sans sucre, solution buvable édulcorée à la saccharine sodique |
Oral solution |
Oral use |
||||||
France |
|
erysimum (sommite fleurie d') (extrait fluide de); pholcodine |
2,4 g/100 g; 0,082 g/100 g |
Polery enfants, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,060 g/100 ml |
Rhinathiol enfants toux seche 0,06 % pholcodine, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,060 g/100 ml |
Respilene enfants 3 mg/5 ml, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,12 g/100 ml |
Pholcodine delalande adultes 0,12 %, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,12 g/100 ml |
Pharmakod 0,12 % adultes toux seche, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,12 g/100 ml |
Rhinathiol adultes toux seche 0,12 % pholcodine, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,12 g/100 ml |
Pholcodine winthrop adultes 0,12 %, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine; sodium (ténoate de) |
0,133 g/100 ml; 1 g |
Trophires adultes, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,12 g/100 ml |
Respilene adultes 0,12 pour cent, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine; sodium (ténoate de) |
0,06 g/100 ml 1 g/100 ml |
Trophires enfants, sirop |
Syrup |
Oral use |
||||||
France |
|
MYRTE (huile essentielle de) (deterpenee); pholcodine |
20 mg; 18 mg |
Atouxx adultes, capsule |
Capsule |
Oral use |
||||||
France |
|
pholcodine |
0,200 g/100 ml |
Humex adultes toux seche pholcodine, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
0,125 g/100 ml |
Humex enfants toux seche pholcodine, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
1,31 mg/ml |
Flucalyptol toux seche pholcodine 1,31 mg/ml, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
1,31 mg/ml |
Biocalyptol, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
131 mg/100 ml |
Flucalyptol toux seche pholcodine 1,31 mg/ml sans sucre, sirop edulcoré à la saccharine sodique et au maltitol liquide |
Syrup |
Oral use |
||||||
France |
|
gaïacol; pholcodine |
19,750 mg/100 ml; 131 mg/100 ml |
Biocalyptol a la pholcodine, sirop |
Syrup |
Oral use |
||||||
France |
|
pholcodine |
131 mg/100 ml |
Biocalyptol 6,55 mg/5 ml sans sucre, sirop édulcoré à la saccharine sodique et au maltitol liquide |
Syrup |
Oral use |
||||||
France |
|
pholcodine; érysimum (extrait sec d') |
0,1/100 ml; 0,150/100 ml |
Pholcodyl, sirop |
Syrup |
Oral use |
||||||
Ireland |
|
Paracetamol, Pseudoephedrine hydrochloride, Pholcodine |
500 mg, 30 mg, 5 mg |
Day Nurse Capsules |
Capsule, hard |
Oral use |
||||||
Ireland |
|
Paracetamol, Pseudoephedrine hydrochloride, Pholcodine |
500 mg, 30 mg, 5 mg |
Solpadeine Cold & Flu Capsules |
Capsule, hard |
Oral use |
||||||
Ireland |
|
Pholcodine |
5 mg |
Pholcodex 5 mg/5 ml oral solution |
Oral solution |
Oral use |
||||||
Ireland |
|
Paracetamol, Pseudoephedrine hydrochloride, Pholcodine |
500 mg 30 mg, 5 mg |
Nirolex day cold & flu capsules |
Capsule, hard |
Oral use |
||||||
Ireland |
|
Paracetamol, Pseudoephedrine hydrochloride, Pholcodine |
1 000 mg/30 ml, 60 mg/30 ml 10 mg/30 ml, |
Nirolex day cold & flu oral solution |
Oral solution |
Oral use |
||||||
Lithuania |
|
Pholcodine, Chlorphenamine, Biclotymol |
120 mg 12 mg 200 mg/100 ml |
Hexapneumine Adults |
Syrup |
Oral use |
||||||
Lithuania |
|
Pholcodine, Chlorphenamine, Biclotymolm |
100 mg 10 mg 150 mg/100 ml |
Hexapneumine Children |
Syrup |
Oral use |
||||||
Luxembourg |
|
Erysimum extr.sec Pholcodine |
0,150 g 0,100 g |
Clarix |
Syrup |
Oral use |
||||||
Luxembourg |
|
Erysimum extr.sec Pholcodine |
0,150 g 0,100 g |
Clarix sans sucre |
Syrup |
Oral use |
||||||
Luxembourg |
|
Pholcodine phenylephrine hcl |
100 mg/100 ml 67 mg/100 ml |
Pectorhinyl |
Syrup |
Oral use |
||||||
Luxembourg |
|
Pholcodine phenylephrine hcl |
50 mg/100 ml 50 mg/100 ml |
pectorhinyl junior |
Syrup |
Oral use |
||||||
Luxembourg |
|
camphre eucalyptol gaiacol phenol pholcodine |
156 mg 120 mg 50 mg 10 mg 10 mg |
Eucalyptine-Pholcodine Adultes |
Suppository |
Rectal use |
||||||
Luxembourg |
|
camphre eucalyptol gaiacol phenol pholcodine |
100 mg 80 mg 30 mg 6 mg 5 mg |
Eucalyptine-Pholcodine Enfants |
Suppository |
Rectal use |
||||||
Luxembourg |
|
doxylamine pholcodine benzoate sodique sulfogaiacol |
5 mg 5 mg 50 mg 47,5 mg |
Pholco Mereprine |
Syrup |
Oral use |
||||||
Luxembourg |
|
pholcodine thiophene carboxylate eucalyptus huile essentielle parahydroxybenzoate de methyle parahydroxybenzoate de propyle |
0,060 g 1 g 0,250 ml 0,080 g 0,030 g/100 ml |
Trophires Enfants |
Syrup |
Oral use |
||||||
Luxembourg |
|
pholcodine thiophene carboxylate eucalyptus huile essentielle parahydroxybenzoate de methyle parahydroxybenzoate de propyle |
0,133 g 1 g 0,250 ml 0,080 g 0,030 g |
Trophires Adultes |
Syrup |
Oral use |
||||||
Luxembourg |
|
Pholcodine |
1,2 mg/ml |
Cotrane Pholcodine |
Syrup |
Oral use |
||||||
Malta |
|
Paracetamol, Pseudoephedrine Hydrochloride, Pholcodine |
500 mg 30 mg 5 mg |
Day Nurse |
Hard capsules |
Oral use |
||||||
Malta |
|
Paracetamol Pseudoephedrine Hydrochloride Pholcodine |
Active Ingredient per 30 ml Paracetamol 1 g Pseudoephedrine Hydrochloride 60 mg Pholcodine 10 mg |
Day Nurse |
Oral solution |
Oral use |
||||||
Malta |
|
Pholcodine, Ephedrine Hydrochloride, Chlorphenamine Maleate |
Pholcodine BP 5,0 mg Ephedrine Hydrochloride BP 8,0 mg Chlorphenamine Maleate BP 2,0 mg |
Cofsed Liquid |
Oral suspension |
Oral use |
||||||
Slovenia |
|
pholcodine |
0,8 mg/ml |
Folkodin Alkaloid 0,8 mg/ml peroralna raztopina za otroke |
Oral solution |
Oral use |
||||||
Slovenia |
|
pholcodine |
1 mg/ml |
Folkodin Alkaloid 1 mg/ml peroralna raztopina |
Oral solution |
Oral use |
||||||
Slovenia |
|
pholcodine |
10 mg |
Folkodin Alkaloid 10 mg trde kapsule |
Capsule, hard |
Oral use |
||||||
Spain |
|
pholcodine; cineol; cherry laurel water; menthol; terpineol; benzocaine |
4 mg 3 mg 5 mg 4 mg 2 mg 1 mg |
Caltoson Balsamico |
Tablets |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Pavacol-D |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Pholcodine Linctus BP |
Oral solution |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Cupal Linctus |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
Psedoephedrine Hydrochloride; Pholcodine; Paracetamol |
60 mg; 10 mg, 1 000 mg |
Day Nurse |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Psedoephedrine Hydrochloride; Pholcodine; Paracetamol |
30 mg, 5 mg, 500 mg |
Day Nurse |
Capsules |
Oral use |
||||||
United Kingdom |
|
Promethazine Hydrochloride, Paracetamol, Dextromethorphan hydrobromide Pholcodine; Pseudoephedrine |
10 mg 500 mg 7,5 mg 5 mg 30 mg |
Day and Night Nurse capsules (nb this is a combination of Day Nurse and Night Nurse capsules in one pack) |
Capsules |
Oral use |
||||||
United Kingdom |
|
Pholcodine; Diphenhydramine hydrochloride |
3,75 mg/5 ml; 12,5 mg/5 ml |
Cough Nurse Night Time Syrup |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
0,1 % w/w |
Bell Pholcodine Linctus |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
0,2 % w/w |
Bell Strong Pholcodine Linctus |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
0,12 % w/w |
Potter's Pholcodine cough pastilles |
Lozenge |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Pholcodine Linctus BP |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Pseudoephedrine Hydrochloride; Pholcodine; Diphenhydramine Hydrochloride; Paracetamol; Ethanol |
6,67 mg, 1,67 mg, 1,67 mg, 100 mg, 96 % 1 ml |
Night time Cold relief |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Pseudoephedrine Hydrochloride; Pholcodine; Paracetamol |
6,67 mg/5 ml, 1,67 mg/5 ml, 100 mg/5 ml |
Day time cold relief |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
10 mg |
Hill's Balsam Dry cough liquid |
Oral solution |
Oral use |
||||||
United Kingdom |
|
pholcodine |
2 mg |
Benylin Children's dry cough |
Syrup |
Oral use |
||||||
United Kingdom |
|
Promethazine Hydrochloride; Pholcodine |
1,5 mg, 1,5 mg |
Tixylix night cough oral solution |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Psedoephedrine Hydrochloride; Chlorpheniramine maleate; Pholcodine |
20 mg, 2 mg, 5 mg |
Tixylix cough and Cold |
Syrup |
Oral use |
||||||
United Kingdom |
|
Pholcodine |
4 mg |
Tixylix Dry cough |
Oral solution |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Pholcodine Cough Linctus |
Syrup |
Oral use |
||||||
United Kingdom |
|
pholcodine |
10 mg |
Strong Pholcodine Linctus BP |
Oral solution |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Pholcodine Linctus BP. |
Oral solution |
Oral use |
||||||
United Kingdom |
|
pholcodine |
10 mg |
Strong Pholcodine Linctus BP. |
Oral solution |
Oral use |
||||||
United Kingdom |
|
diphenhydramine Chloride; Pholcodine |
12,5 mg 3,75 mg |
Boots cough relief for Adults Liquid |
Oral solution |
Oral use |
||||||
United Kingdom |
|
diphenhydramine Chloride; Pholcodine |
12,5 mg, 1,5 mg |
Boots cough relief for Children Syrup |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Pholcodine |
2 mg |
Boots Dry Cough Syrup 6 years+ |
Syrup |
Oral use |
||||||
United Kingdom |
|
Paracetamol, Pseudoephedrine Hydrochloride, Pholcodine |
3,333 % w/v, 0,2 % w/v, 0,033 % w/v |
Boots Night cough relief oral solution |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Paracetamol; Pseudoephedrine Hydrochloride; Pholcodine |
3,333 % w/v, 0,2 % w/v 0,033 % w/v |
Boots Day cold and Flu relief oral solution |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Paracetamol; Pseudoephedrine Hydrochloride; Diphenhydramine Hydrochloride; Pholcodine |
3,333 % w/v, 0,2 % w/v, 0,083 % w/v, 0,033 % w/v |
Boots Pharmacy cold and Flu night liquid |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Pholcodine; Paracetamol; Psedoephedrine Hydrochloride |
5 mg 500 mg 30 mg |
Boots Pharmacy cold and Flu Day capsules |
Capsules |
Oral use |
||||||
United Kingdom |
|
Pholcodine; Paracetamol; Diphenhydramine Psedoephedrine Hydrochloride |
5 mg, 500 mg, 12,5 mg 30 mg |
Boots Pharmacy Cold and Flu Night Capsules |
Capsules |
Oral use |
||||||
United Kingdom |
|
pholcodine |
0,1 % w/w |
Boots Pholcodine Linctus BP |
Oral solution |
Oral use |
||||||
United Kingdom |
|
Pholcodine; Paracetamol; diphenhydramine hydrochloride; Pseudoephedrine hydrochloride |
5 mg 500 mg 12,5 mg 30 mg |
Boots Pharmacy Cold and Flu 24 Hour Capsules (Nb this is a pack containing a combination of Day and Night capsules) |
Capsules |
Oral use |
||||||
United Kingdom |
|
Pholcodine; Ephedrine Hydrochloride; Chlorpheniramine maleate |
5 mg, 8 mg, 2 mg |
Cofsed Linctus |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
Pholcodine; Ephedrine Hydrochloride; Chlorpheniramine maleate |
2 mg, 4 mg, 1 mg |
Cofsed Paediatric Linctus |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Care Pholcodine 5 mg/5 ml Oral solution |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
2 mg |
Galenphol Paediatric Linctus oral liquid 2,0 mg/5 ml |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
10 mg |
Galenphol Strong Linctus |
Oral solution |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Covonia Dry cough sugar free formula |
Oral liquid |
Oral use |
||||||
United Kingdom |
|
pholcodine |
5 mg |
Pholcodine Linctus BP |
Oral solution |
Oral use |
||||||
United Kingdom |
|
pholcodine |
10 mg |
Strong Pholcodine Linctus |
Oral solution |
Oral use |
ANNEX IV
LIST OF THE INVENTED NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Marketing Authorisation Holder |
Invented name |
Strength |
Pharmaceutical Form |
Route of administration |
|||||||
Austria |
|
BufloMed ‧S.Med‧ 300 mg Filmtabletten |
300 mg |
film-coated tablet |
oral use |
|||||||
Austria |
|
BufloMed ‧S.Med‧ retard 600 mg Filmtabletten |
600 mg |
prolonged-release tablet |
oral use |
|||||||
Belgium |
|
Loftyl |
150 mg |
coated tablet |
oral use |
|||||||
Belgium |
|
Loftyl |
50 mg/5 ml |
solution for injection |
intramuscular and intravenous use |
|||||||
Cyprus |
|
Ikelan solution for injection or infusion 50 mg/5 ml |
50 mg/5 ml |
injection |
Intramuscular and intravenous use |
|||||||
France |
|
BUFLOMEDIL BIOGARAN 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL QUALIMED 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL TEVA 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL ACTAVIS 150 mg, comprimé |
150 mg |
Tablet |
oral use |
|||||||
France |
|
LOFTYL 50 mg/5 ml, solution injectable |
50 mg/5 ml |
Solution for injection |
Intramuscular and intravenous use |
|||||||
France |
|
LOFTYL 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL ARROW 150 mg, comprimé |
150 mg |
Tablet |
oral use |
|||||||
France |
|
FONZYLANE 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL CRISTERS 150 mg, comprimé |
150 mg |
Tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL EG 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL RATIOPHARM 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL MYLAN 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL RPG 150 mg, comprimé pelliculé |
150 mg |
Film-coated tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL RPG 150 mg, comprimé |
150 mg |
Tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL SANDOZ 150 mg, comprimé |
150 mg |
Tablet |
oral use |
|||||||
France |
|
BUFLOMEDIL ZYDUS 150 mg, comprimé |
150 mg |
Tablet |
oral use |
|||||||
Germany |
|
Bufedil long Retardtabletten |
600 mg |
Prolonged-release tablet |
oral use |
|||||||
Germany |
|
Buflomedil AbZ, 600 mg Retardtabletten |
600 mg |
Prolonged-release tablet |
oral use |
|||||||
Germany |
|
Buflo-Puren 300 |
300 mg |
Film-coated tablet |
oral use |
|||||||
Germany |
|
BUFLO-Puren 600 retard |
600 mg |
Prolonged-release tablet |
oral use |
|||||||
Germany |
|
Buflomedil-CT 150 mg Filmtabletten |
150 mg |
Film-coated tablet |
oral use |
|||||||
Germany |
|
Buflomedil-CT 300 mg Filmtabletten |
300 mg |
Film-coated tablet |
oral use |
|||||||
Germany |
|
Buflomedil-CT 50 mg/5 ml Ampullen |
50 mg / 5 ml |
Solution for injection, solution for infusion |
Intravenous and intramuscular use |
|||||||
Germany |
|
Buflomedil-CT 600 mg Retardtabletten |
600 mg |
Prolonged-release tablet |
oral use |
|||||||
Germany |
|
Buflomedil-ratiopharm 300 mg Filmtabletten |
300 mg |
Film-coated tablet |
oral use |
|||||||
Germany |
|
Buflomedil-ratiopharm 600 mg Retardtabletten |
600 mg |
Prolonged-release tablet |
oral use |
|||||||
Germany |
|
Complamin Buflomedil 600 mg retard |
600 mg |
Prolonged-release tablet |
oral use |
|||||||
Germany |
|
Complamin Buflomedil Injekt |
50 mg / 5 ml |
Solution for injection |
intravenous and intramuscular use |
|||||||
Germany |
|
Defluina peri |
300 mg |
Film-coated tablet |
oral use |
|||||||
Germany |
|
Deflunia peri mite |
150 mg |
Film-coated tablet |
oral use |
|||||||
Germany |
|
Buflomedil Stada 150 mg Filmtabletten |
150 mg |
Film-coated tablet |
oral use |
|||||||
Germany |
|
Buflomedil Stada 300 mg Filmtabletten |
300 mg |
Film-coated tablet |
oral use |
|||||||
Greece |
|
THIOCODIN |
150 MG/TAB |
COATED TABLET |
oral use |
|||||||
Greece |
|
THIOCODIN |
300 MG/TAB |
COATED TABLET |
oral use |
|||||||
Greece |
|
LOFTYL |
150 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
LOFTYL |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
LOFTYL |
150 MG/ML |
ORAL DROPS SOLUTION |
oral use |
|||||||
Greece |
|
LOFTYL |
50 MG/5 ML |
SOLUTION FOR INJECTION |
INTRAVENOUS INFUSION, INTRAVENOUS INJECTION, INTRAMUSCULAR |
|||||||
Greece |
|
LOFTYL |
600 MG/TAB |
CONTROLLED RELEASE TABLET |
oral use |
|||||||
Greece |
|
BOTAMIRAL |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
VANOGEL |
150 MG/ML |
ORAL DROPS SOLUTION |
oral use |
|||||||
Greece |
|
VANOGEL |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
VARDOLIN |
150 MG/ML |
ORAL DROPS SOLUTION |
oral use |
|||||||
Greece |
|
VARDOLIN |
150 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
VARDOLIN |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
VARDOLIN |
600 MG/TAB |
CONTROLLED RELEASE TABLET |
oral use |
|||||||
Greece |
|
FLUBIR |
150 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
FLUBIR |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
ZELIAN |
150 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
ZELIAN |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
CHLOROFARM-S |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
BLADIRON |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
BLADIRON |
150 MG/ML |
ORAL DROPS SOLUTION |
oral use |
|||||||
Greece |
|
IRRODAN RETARD |
600 MG/TAB |
SUSTAINED RELEASE TABLET |
oral use |
|||||||
Greece |
|
BUFLODIL |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
PENPURIN |
150 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
PENPURIN |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
PENPURIN |
150 MG/ML |
ORAL DROPS SOLUTION |
oral use |
|||||||
Greece |
|
PENPURIN |
600 MG/TAB |
CONTROLLED RELEASE TABLET |
oral use |
|||||||
Greece |
|
SULODIL |
300 MG/TAB |
FILM COATED TABLET |
oral use |
|||||||
Greece |
|
SULODIL |
600 MG/TAB |
CONTROLLED RELEASE TABLET |
oral use |
|||||||
Italy |
|
LOFTYL |
150 mg/ml |
oral drop, solution |
oral use |
|||||||
Italy |
|
LOFTYL |
10 mg/ml |
solution for injection |
intramuscular and intravenous use |
|||||||
Italy |
|
LOFTYL |
300 mg/10 ml |
oral solution |
oral use |
|||||||
Italy |
|
LOFTYL |
600 mg |
prolonged-release tablet |
oral use |
|||||||
Italy |
|
LOFTYL |
300 mg |
tablet |
oral use |
|||||||
Italy |
|
IRRODAN |
10 mg/ml |
solution for injection |
intramuscular and intravenous use |
|||||||
Italy |
|
IRRODAN |
150 mg/ml |
oral drop, solution |
oral use |
|||||||
Italy |
|
IRRODAN |
300 mg |
tablet |
oral use |
|||||||
Italy |
|
BUFLOCIT |
300 mg |
capsule, hard |
oral use |
|||||||
Italy |
|
BUFLOCIT |
150 mg |
capsule, hard |
oral use |
|||||||
Italy |
|
BUFLOCIT |
600 mg |
prolonged-release tablet |
oral use |
|||||||
Luxembourg |
|
Loftyl |
50 mg |
solution for injection |
Intramuscular and intravenous use |
|||||||
Luxembourg |
|
Loftyl |
150 mg |
tablets |
oral use |
|||||||
Portugal |
|
Loftyl 300 |
300 mg |
Coated tablet |
oral use |
|||||||
Portugal |
|
Loftyl Forte |
600 mg |
Prolonged-release tablet |
oral use |
|||||||
Netherlands |
|
Loftyl |
150 mg |
tablets |
oral use |
|||||||
Spain |
|
LOFTON 150 mg comprimidos recubiertos |
150 mg |
coated tablet |
oral use |
|||||||
Spain |
|
LOFTON 150 mg/ml gotas orales en solución |
150 mg/ml |
oral drops solution |
oral use |
|||||||
Poland |
|
Buvasodil |
150 mg |
film coated tablets |
oral use |
|||||||
Poland |
|
Buvasodil |
300 mg |
film coated tablets |
oral use |